Cargando…
A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms
In Parkinson’s disease (PD), a large number of symptoms affecting the peripheral and central nervous system precede, develop in parallel to, the cardinal motor symptoms of the disease. The study of these conditions, which are often refractory to and may even be exacerbated by standard dopamine repla...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227396/ https://www.ncbi.nlm.nih.gov/pubmed/34070345 http://dx.doi.org/10.3390/biomedicines9060598 |
_version_ | 1783712513950482432 |
---|---|
author | Masini, Débora Plewnia, Carina Bertho, Maëlle Scalbert, Nicolas Caggiano, Vittorio Fisone, Gilberto |
author_facet | Masini, Débora Plewnia, Carina Bertho, Maëlle Scalbert, Nicolas Caggiano, Vittorio Fisone, Gilberto |
author_sort | Masini, Débora |
collection | PubMed |
description | In Parkinson’s disease (PD), a large number of symptoms affecting the peripheral and central nervous system precede, develop in parallel to, the cardinal motor symptoms of the disease. The study of these conditions, which are often refractory to and may even be exacerbated by standard dopamine replacement therapies, relies on the availability of appropriate animal models. Previous work in rodents showed that injection of the neurotoxin 6-hydroxydopamine (6-OHDA) in discrete brain regions reproduces several non-motor comorbidities commonly associated with PD, including cognitive deficits, depression, anxiety, as well as disruption of olfactory discrimination and circadian rhythm. However, the use of 6-OHDA is frequently associated with significant post-surgical mortality. Here, we describe the generation of a mouse model of PD based on bilateral injection of 6-OHDA in the dorsal striatum. We show that the survival rates of males and females subjected to this lesion differ significantly, with a much higher mortality among males, and provide a protocol of enhanced pre- and post-operative care, which nearly eliminates animal loss. We also briefly discuss the utility of this model for the study of non-motor comorbidities of PD. |
format | Online Article Text |
id | pubmed-8227396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82273962021-06-26 A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms Masini, Débora Plewnia, Carina Bertho, Maëlle Scalbert, Nicolas Caggiano, Vittorio Fisone, Gilberto Biomedicines Article In Parkinson’s disease (PD), a large number of symptoms affecting the peripheral and central nervous system precede, develop in parallel to, the cardinal motor symptoms of the disease. The study of these conditions, which are often refractory to and may even be exacerbated by standard dopamine replacement therapies, relies on the availability of appropriate animal models. Previous work in rodents showed that injection of the neurotoxin 6-hydroxydopamine (6-OHDA) in discrete brain regions reproduces several non-motor comorbidities commonly associated with PD, including cognitive deficits, depression, anxiety, as well as disruption of olfactory discrimination and circadian rhythm. However, the use of 6-OHDA is frequently associated with significant post-surgical mortality. Here, we describe the generation of a mouse model of PD based on bilateral injection of 6-OHDA in the dorsal striatum. We show that the survival rates of males and females subjected to this lesion differ significantly, with a much higher mortality among males, and provide a protocol of enhanced pre- and post-operative care, which nearly eliminates animal loss. We also briefly discuss the utility of this model for the study of non-motor comorbidities of PD. MDPI 2021-05-25 /pmc/articles/PMC8227396/ /pubmed/34070345 http://dx.doi.org/10.3390/biomedicines9060598 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Masini, Débora Plewnia, Carina Bertho, Maëlle Scalbert, Nicolas Caggiano, Vittorio Fisone, Gilberto A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms |
title | A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms |
title_full | A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms |
title_fullStr | A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms |
title_full_unstemmed | A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms |
title_short | A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms |
title_sort | guide to the generation of a 6-hydroxydopamine mouse model of parkinson’s disease for the study of non-motor symptoms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227396/ https://www.ncbi.nlm.nih.gov/pubmed/34070345 http://dx.doi.org/10.3390/biomedicines9060598 |
work_keys_str_mv | AT masinidebora aguidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT plewniacarina aguidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT berthomaelle aguidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT scalbertnicolas aguidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT caggianovittorio aguidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT fisonegilberto aguidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT masinidebora guidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT plewniacarina guidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT berthomaelle guidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT scalbertnicolas guidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT caggianovittorio guidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms AT fisonegilberto guidetothegenerationofa6hydroxydopaminemousemodelofparkinsonsdiseaseforthestudyofnonmotorsymptoms |